Export 65 results:
Author [ Title(Asc)] Type Year
Filters: Author is Belo, L.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Belo, L., Santos-Silva, A., Quintanilha, A., & Rebelo, I. (2008). Similarities between pre-eclampsia and atherosclerosis: A protective effect of physical exercise?. Current Medicinal Chemistry, 15(22), 2223 - 2229.
Xavier, P., Belo, L., Beires, J., Rebelo, I., et al. (2006). Serum levels of VEGF and TNF-a and their association with C-reactive protein in patients with endometriosis. Archives of Gynecology and Obstetrics, 273(4), 227 - 231.
R
Costa, E., Pereira, B. J. G., Rocha-Pereira, P., Rocha, S., et al. (2008). Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients. American Journal of Nephrology, 28(4), 677 - 683.
Catarino, C., Rebelo, I., Belo, L., Rocha, S., et al. (2008). Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies. Thrombosis Research, 123(2), 219 - 224.
Teixeira, A. M., Garrido, P., Santos, P., Alves, R., et al. (2010). Recombinant human erythropoietin treatment protects the cardio-renal axis in a model of moderate chronic renal failure. Renal Failure, 32(9), 1073 - 1080.
P
Rocha, S., Rebelo, I., Costa, E., Catarino, C., et al. (2005). Protein deficiency balance as a predictor of clinical outcome in hereditary spherocytosis. European Journal of Haematology, 74(5), 374 - 380.
Paiva-Martins, F., Silva, A., Almeida, V., Carvalheira, M., et al. (2013). Protective activity of hydroxytyrosol metabolites on erythrocyte oxidative-induced hemolysis. Journal of Agricultural and Food Chemistry, 61(27), 6636 - 6642.
Coimbra, S., Oliveira, H., Belo, L., Figueiredo, A., et al. (2013). Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: A follow-up study. American Journal of Clinical Dermatology, 14(1), 49 - 53.
Rocha, S., Vitorino, R. M. P., Lemos-Amado, F. M., Castro, E. B., et al. (2008). Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis. Blood Cells, Molecules, and Diseases, 41(1), 5 - 9.
Belo, L., Santos-Silva, A., Quintanilha, A., & Rebelo, I. (2006). Pre-eclampsia versus cardiovascular disease versus CRP. Current Hypertension Reviews, 2(4), 317 - 323.
Paiva-Martins, F., Fernandes, J., Santos, V., Silva, L., et al. (2010). Powerful protective role of 3,4-dihydroxyphenylethanol-elenolic acid dialdehyde against erythrocyte oxidative-Lnduced hemolysis. Journal of Agricultural and Food Chemistry, 58(1), 135 - 140.
O
Belo, L., Santos-Silva, A., Caslake, M., Pereira-Leite, L., et al. (2005). Oxidized-LDL levels in normal and pre-eclamptic pregnancies: Contribution of LDL particle size [2]. Atherosclerosis, 183(1), 185 - 186.
Ribeiro, S., Faria, M. D. S., Silva, G., Nascimento, H., et al. (2012). Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: Influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene. Hemodialysis International, 16(4), 481 - 490.
N
Pereira, R., Costa, E., Gonçalves, M., Miranda, V., et al. (2010). Neutrophil and monocyte activation in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure. Hemodialysis International, 14(3), 295 - 301.
Costa, E., Rocha, S., Rocha-Pereira, P., Nascimento, H., et al. (2008). Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients. American Journal of Nephrology, 28(6), 935 - 940.
M
Costa, E., Coimbra, J., Catarino, C., Ribeiro, S., et al. (2012). Major determinants of BMP-2 serum levels in hemodialysis patients. Renal Failure, 34(10), 1355 - 1358.
Ribeiro, S., Do Sameiro Faria, M., Mascarenhas-Melo, F., Freitas, I., et al. (2012). Main determinants of PON1 activity in hemodialysis patients. American Journal of Nephrology, 36(4), 317 - 323.
L
Nascimento, H., Silva, L. L., Lourenço, P., Vieira, E., et al. (2009). Lipoprotein(a) levels in obese portuguese children and adolescents: Contribution of the pentanucleotide repeat (TTTTA)n polymorphism in the apolipoprotein(a) gene. Archives of Pediatrics and Adolescent Medicine, 163(4), 393 - 394.
Portelinha, A., Belo, L., Cerdeira, A. S., Braga, J., et al. (2010). Lipid levels including oxidized LDL in women with history of preeclampsia. Hypertension in pregnancy : official journal of the International Society for the Study of Hypertension in Pregnancy, 29(1), 93 - 100.
Rocha, S., Costa, E., Coimbra, S., Nascimento, H., et al. (2009). Linkage of cytosolic peroxiredoxin 2 to erythrocyte membrane imposed by hydrogen peroxide-induced oxidative stress. Blood Cells, Molecules, and Diseases, 43(1), 68 - 73.
Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2012). Letter to the Editor: A potential mechanism for the pathogenesis of psoriasis vulgaris. International Journal of Dermatology.
Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2013). Letter to the editor: A potential mechanism for the pathogenesis of psoriasis vulgaris. International Journal of Dermatology, 52(11), 1429 - 1432.
Belo, L., Caslake, M., Santos-Silva, A., Castro, E. M. B., et al. (2004). LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: A longitudinal study. Atherosclerosis, 177(2), 391 - 399.
I
Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2010). Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy. British Journal of Dermatology, 163(6), 1282 - 1290.
Catarino, C., Santos-Silva, A., Belo, L., Rocha-Pereira, P., et al. (2012). Inflammatory disturbances in preeclampsia: Relationship between maternal and umbilical cord blood. Journal of Pregnancy, 2012.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@i3s.up.pt | © copyright 2010 ibmc